SCHEMBL2666140

SCHEMBL2666140

CCCCC(=O)N1CCC(N(C(N)=O)C2CCCCC2)CC1

nearest known ligand 0.50

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
GNAI3 P08754 9/20 0.50
GNAI1 P63096 9/20 0.50
GNAO1 P09471 8/20 0.50
L3MBTL1 Q9Y468 2/20 0.50
MEN1 O00255 2/20 0.50
KMT2A Q03164 2/20 0.50
TDP1 Q9NUW8 1/20 0.50
POLB P06746 1/20 0.47
MAPT P10636 1/20 0.47
NPC1 O15118 1/20 0.44
BACE1 P56817 2/20 0.41
CTSD P07339 1/20 0.41
ALDH1A1 P00352 1/20 0.40
HSD11B1 P28845 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2606369 0.92 GNAI3 (0.42) GNAI3GNAI1GNAO1L3MBTL1MEN1
SCHEMBL2606492 0.88 NPC1 (0.54) GNAI3GNAI1GNAO1L3MBTL1MEN1
SCHEMBL9072449 0.85 EPHX2 (0.51) MEN1KMT2AMAPTALDH1A1HSD11B1
SCHEMBL2606484 0.84 NPC1 (0.40) GNAI3GNAI1GNAO1L3MBTL1MEN1
SCHEMBL2606383 0.82 ALDH1A1 (0.42) MEN1KMT2APOLBMAPTNPC1
SCHEMBL2606486 0.82 HSD11B1 (0.54) MEN1KMT2AMAPTALDH1A1HSD11B1
SCHEMBL2606380 0.81 GNAI3 (0.36) GNAI3GNAI1GNAO1L3MBTL1MEN1
SCHEMBL2606469 0.81 L3MBTL1 (0.46) L3MBTL1MEN1KMT2APOLBMAPT
SCHEMBL10272978 0.79 MEN1 (0.43) L3MBTL1MEN1KMT2ATDP1POLB
SCHEMBL2606485 0.79 ALDH1A1 (0.41) MEN1KMT2AMAPTALDH1A1HSD11B1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2444397-A1 Heteroaryl-ureas and their use as glucokinase activators Novo Nordisk A/S (DK) 2012-04-25 EP disclosed
WO-2005066145-A1 HETEROARYL-UREAS AND THEIR USE AS GLUCOKINASE ACTIVATORS NOVO NORDISK A/S (DK) 2005-07-21 WO disclosed